269 related articles for article (PubMed ID: 30153666)
1. Prognostic Cardiovascular Markers in Chronic Kidney Disease.
Chen SC; Huang JC; Su HM; Chiu YW; Chang JM; Hwang SJ; Chen HC
Kidney Blood Press Res; 2018; 43(4):1388-1407. PubMed ID: 30153666
[TBL] [Abstract][Full Text] [Related]
2. Interankle systolic blood pressure difference and renal outcomes in patients with chronic kidney disease.
Chen SC; Tsai YC; Huang JC; Lee SC; Chang JM; Hwang SJ; Chen HC
Nephrology (Carlton); 2016 May; 21(5):379-86. PubMed ID: 26370877
[TBL] [Abstract][Full Text] [Related]
3. Arterial stiffness and pulse pressure in CKD and ESRD.
Briet M; Boutouyrie P; Laurent S; London GM
Kidney Int; 2012 Aug; 82(4):388-400. PubMed ID: 22534962
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory arterial stiffness in chronic kidney disease: a methodological review.
László A; Reusz G; Nemcsik J
Hypertens Res; 2016 Apr; 39(4):192-8. PubMed ID: 26631849
[TBL] [Abstract][Full Text] [Related]
5. Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.
Bansal N
Semin Nephrol; 2017 Mar; 37(2):120-131. PubMed ID: 28410646
[TBL] [Abstract][Full Text] [Related]
6. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic Kidney Disease: The Value of Left Atrial Function and Volume.
Kadappu KK; Abhayaratna K; Boyd A; French JK; Xuan W; Abhayaratna W; Thomas L
J Am Soc Echocardiogr; 2016 Apr; 29(4):359-67. PubMed ID: 26743735
[TBL] [Abstract][Full Text] [Related]
7. Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.
Kim CS; Bae EH; Ma SK; Park SK; Lee JY; Chung W; Lee K; Kim YH; Oh KH; Ahn C; Kim SW;
Clin Exp Nephrol; 2017 Aug; 21(4):608-616. PubMed ID: 27514393
[TBL] [Abstract][Full Text] [Related]
8. Compliance Index, a Marker of Peripheral Arterial Stiffness, may Predict Renal Function Decline in Patients with Chronic Kidney Disease.
Kuo TH; Yang DC; Lin WH; Tseng CC; Chen JY; Ho CS; Cheng MF; Tsai WC; Wang MC
Int J Med Sci; 2015; 12(7):530-7. PubMed ID: 26180508
[TBL] [Abstract][Full Text] [Related]
9. Early markers of cardiovascular risk in chronic kidney disease.
Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease in children with chronic kidney disease.
Mitsnefes MM
Adv Chronic Kidney Dis; 2005 Oct; 12(4):397-405. PubMed ID: 16198279
[TBL] [Abstract][Full Text] [Related]
11. Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease.
Zoccali C; London G
Nephrol Dial Transplant; 2015 Mar; 30(3):352-7. PubMed ID: 25712936
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1-3.
Pluta A; Stróżecki P; Krintus M; Odrowąż-Sypniewska G; Manitius J
Ren Fail; 2015 Aug; 37(7):1105-10. PubMed ID: 26156686
[TBL] [Abstract][Full Text] [Related]
13. Role of pulse pressure on cardiovascular risk in chronic kidney disease patients.
Fernandez-Fresnedo G; Rodrigo E; de Francisco AL; de Castro SS; Castañeda O; Arias M
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S246-9. PubMed ID: 17130269
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
Guérin AP; Pannier B; Marchais SJ; London GM
Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):105-10. PubMed ID: 16481874
[TBL] [Abstract][Full Text] [Related]
15. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.
Lash JP; Ricardo AC; Roy J; Deo R; Fischer M; Flack J; He J; Keane M; Lora C; Ojo A; Rahman M; Steigerwalt S; Tao K; Wolf M; Wright JT; Go AS;
Am J Kidney Dis; 2016 Oct; 68(4):545-553. PubMed ID: 27209443
[TBL] [Abstract][Full Text] [Related]
16. Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).
Formentini I; Bobadilla M; Haefliger C; Hartmann G; Loghman-Adham M; Mizrahi J; Pomposiello S; Prunotto M; Meier M
Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3():iii81-8. PubMed ID: 22734108
[TBL] [Abstract][Full Text] [Related]
17. Pediatric CKD and cardiovascular disease.
Safder O; Al sharif S; Kari JA
Cardiovasc Hematol Disord Drug Targets; 2014; 14(3):177-84. PubMed ID: 24720458
[TBL] [Abstract][Full Text] [Related]
18. The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study.
Cseprekál O; Egresits J; Tabák Á; Nemcsik J; Járai Z; Babos L; Fodor E; Farkas K; Godina G; Kárpáthi KI; Kerkovits L; Marton A; Nemcsik-Bencze Z; Németh Z; Sallai L; Kiss I; Tislér A
J Hum Hypertens; 2016 Jul; 30(7):449-55. PubMed ID: 26424101
[TBL] [Abstract][Full Text] [Related]
19. Association of Arterial Stiffness With Chronic Kidney Disease Progression and Mortality.
Voicehovska JG; Bormane E; Grigane A; Moisejevs G; Moreino E; Trumpika D; Voicehovskis VV
Heart Lung Circ; 2021 Nov; 30(11):1694-1701. PubMed ID: 34503918
[TBL] [Abstract][Full Text] [Related]
20. [Biomarkers in Chronic Kidney Disease].
Munguía-Miranda C; Paniagua-Sierra JR
Rev Med Inst Mex Seguro Soc; 2017; 55(Suppl 2):S143-50. PubMed ID: 29697235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
